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Microorganisms within spacecraft have traditionally been monitored with culture-based 
techniques.  These techniques involve growth of environmental samples (cabin water, air or 
surfaces) on agar-type media for several days, followed by visualization of resulting colonies 
or return of samples to Earth for ground-based analysis.  Data obtained over the past 4 
decades have enhanced our understanding of the microbial ecology within space stations.  
However, the approach has been limited by the following factors: i) Many microorganisms 
(estimated > 95%) in the environment cannot grow on conventional growth media; ii) 
Significant time lags (3-5 days for incubation and up to several months to return samples to 
ground); iii) Condensation in contact slides hinders colony counting by crew; and iv) Growth 
of potentially harmful microorganisms, which must then be disposed of safely. This report 
describes the operation of a new culture-independent technique onboard the ISS for rapid 
analysis (within minutes) of endotoxin and β-1, 3-glucan, found in the cell walls of gram-
negative bacteria and fungi, respectively.  The technique involves analysis of environmental 
samples with the Limulus Amebocyte Lysate (LAL) assay in a handheld device, known as the 
Lab-On-a-Chip Application Development Portable Test System (LOCAD-PTS).  LOCAD-
PTS was launched to the ISS in December 2006, and here we present data obtained from 
Mach 2007 until the present day.  These data include a comparative study between LOCAD-
PTS analysis and existing culture-based methods; and an exploratory survey of surface 
endotoxin and β-1, 3-glucan throughout the ISS. While a general correlation between 
LOCAD-PTS and traditional culture-based methods should not be expected, we will suggest 
new requirements for microbial monitoring based upon culture-independent parameters 
measured by LOCAD-PTS. 
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I. Introduction 
The International Space Station (ISS) is an enclosed habitat, where crews of three to six astronauts live and work 
for several months at a time.  It was recognized early on in the history of the space program that microorganisms 
might pose a health hazard to the crew if left unmonitored1. Since the first space flight, by Yuri Gagarin in 1961, 
microorganisms within spacecraft have traditionally been analyzed with culture-based techniques, both in the United 
States2-5 and Russia6-13. 
The current microbial requirements for the ISS are shown in Table 1 below.  These requirements are currently 
verified by the Crew Health Care System (CHeCS), an onboard kit consisting of various culture-based methods for 
the analysis of air and water, as well as surfaces.  Surfaces are analyzed with ‘Contact Slides’ (Biotest, Rocaway, 
NJ), applied to a surface, incubated for 3-5 days, followed by visualization of colonies.  More sophisticated analyses 
are performed on the ground following the return of flight samples to NASA Johnson Space Center. 
 
Table 1. Current Microbial Requirements for Internal Surfaces of the International Space Station (ISS) 
 
MISSION PHASE Colony Forming Units (CFU)/100cm2 
Bacteria (CFU) Fungi (CFU) 
In-flight 10 000 100 
Pre-flight 500 10 
Requirements from 1ISS Mission Operations Requirements Document (MORD) section “7.4.4: In-flight 
environmental microbiology specifications and monitoring of air and surfaces” and “7.4.3 Preflight 
Environmental Microbiology Specifications and Monitoring of Air and Surfaces”. 
 
These culture-based techniques have provided extremely useful data regarding 
the type and distribution of microorganisms in space stations, from Salyut13 to the 
ISS2. However, as with all techniques, there are several limitations; in this case, of 
using a system to detect microorganisms based on their ability to grow on culture 
media.  Four of these limitations include: i) More than 95% microbial species 
cannot be cultured in conventional growth media14-15; ii) Significant time lags often 
occur between onboard sampling and colony visualization (3-5 days) and ground-
based analysis (as long as several months); iii) Colonies are often difficult to 
visualize due to condensation within contact slide media plates (see Fig. 1); iv) 
Culture-based techniques involve growth of potentially harmful microorganisms, 
which must then be disposed of safely. 
 
There are a variety of techniques used to detect microorganisms, each suitable 
to a particular purpose.  These techniques may test parameters such as a 
microorganism’s ability to grow, metabolic activity, or the presence of 
characteristic biological molecules.  The Lab-On-a-Chip Application Development 
Portable Test System (LOCAD-PTS) detects the latter i.e., the presence of 
biological molecules found in the cell walls of bacteria and fungi.  These molecules 
include: i) Endotoxin, ii) β-1, 3-glucan and iii) lipoteichoic acid/peptidoglyan.  
A common classification in microbiology is to divide bacteria into two groups: 
Gram-negative and Gram-positive.  The ‘Gram’ refers to the Gram stain, developed 
by Hans Christian Gram in 1884, to differentiate Klebsiella pneumoniae from pneumococci16. With this method, 
Gram-negative bacteria stain pink and Gram-positive bacteria stain purple, and is related to structure of their cell 
walls.  Endotoxin - the bacterial form of which is also known as lipopolysaccharide (LPS) - is found predominantly 
in the cell wall outer membrane of Gram-negative bacteria17, whereas lipoteichoic acid and peptidoglycan are found 
in the cell walls of Gram-positive bacteria.  The polysaccharide β-1, 3-glucan is not found in either group of 
bacteria, but only in the cell walls of fungi such as the baker’s yeast, Saccharomyces cerevisiae. 
LOCAD-PTS detects endotoxin and β-1, 3-glucan with the Limulus amebocyte lysate (LAL) assay.  The LAL 
assay is derived from early discoveries that microbial infection causes blood clots in the horseshoe crab Limulus 
polyphemus18 and that the causative agent is endotoxin19-21. In 1977, the LAL assay replaced the rabbit pyrogen test 
for endotoxin22 and in 1983, the Food and Drug Administration (FDA) certified the LAL assay as a standard test for 
endotoxins.   
Figure 1. Condensation 
within a ‘Contact Slide’ 
onboard ISS 
 
American Institute of Aeronautics and Astronautics 
092407 
 
3
 
The LAL assay is now used routinely to monitor endotoxin, as an important entity by itself and as a proxy for 
Gram-negative bacteria, in a wide range of products and applications.  These include: dairy products23, eye surgery 
24, heart surgery25, dental surgery26, diagnosis of gram-negative peritonitis27, biofilms in dialysis systems28, organs 
for transplantation29, microbial contamination of metal-working fluids30, air monitoring in factories31, research of 
cyanobacterial blooms32, in plasmid-DNA based gene 
therapy to verify that gene vectors are endotoxin-
free33,34. 
While the LAL assay can be coupled to a 
turbidimetric reaction, this is time-consuming and labor-
intensive.  To address this issue, the LAL assay was 
coupled to a colorimetric reaction (see Fig. 2) by 
Charles River Laboratories Inc. (Charleston, SC) to 
generate the Endosafe™ Portable Test System (PTS). 
The Endosafe PTS is a portable spectrophotometer 
coupled with a range of thumb-sized cartridges in which 
the colorimetric LAL reaction takes place. Each LAL-
containing cartridge also contains p-nitroalanine, which 
is converted into a yellow/green product if endotoxin is 
present in the original sample. 
The Endosafe™ PTS was then modified by the LOCAD Team at NASA Marshall Space Flight Center (MSFC) 
to deem it flight qualified, and ensure it could withstand the rigors of launch, and the space environment. The 
instrument, along with a novel sample collection device, became known as the LOCAD-PTS.  LOCAD-PTS 
therefore consists of a modified Endosafe™ PTS, plus a surface sampling/processing kit that enables astronauts to 
collect surface samples, dilute them with endotoxin-free water, mix, and then dispense as a liquid into a LOCAD-
PTS cartridge. 
LOCAD-PTS was launched to the International Space Station (ISS) aboard Space Shuttle Discovery in 
December 2006 and remains onboard the ISS. This report describes preliminary results from eleven operations of 
LOCAD-PTS onboard the ISS from March 2007 until the spring of 2008.  
This report describes LOCAD-PTS operations performed on the ISS to address five main objectives: i) 
Demonstrate correct instrument function in a mission environment (success criterion: mid/high reading for positive 
control); ii) Demonstrate crew handling of LOCAD-PTS supplies without biological contamination e.g. from skin 
(success criterion: <0.05EU/ml reading for negative control); iii) Demonstrate consistent and reliable crew 
operations of LOCAD-PTS in a mission environment; iv) Conduct general survey of surface endotoxin within Node 
1 and the US Lab; and iv) Compare and contrast endotoxin data with colony forming unit (CFU) data obtained from 
adjacent areas at each site. 
 
 
 
Figure 2. Colorimetric LAL cascade 
 
American Institute of Aeronautics and Astronautics 
092407 
 
4
 
II. Hardware 
A. Reader   
The LOCAD-PTS Reader is a handheld integrated 
spectrophotometer, heater, pump with built-in electronics and software 
to perform various assays with LOCAD-PTS Cartridges (see Fig. 3).  
Two Readers were chosen for space flight (one as back-up) and both 
were manufactured and modified for space flight by Charles River 
Laboratories.  Modifications of the commercially available Readers 
were minor as far as assay function was concerned and included 
removal of the battery from the Reader to comply with ISS safety 
regulations.  
B. Cartridges 
LOCAD-PTS LAL cartridges (manufactured by CRL) were 
approximately 10 cm long, 3 cm wide and inserted into the Reader to 
perform each assay (see Fig. 4).  Each cartridge was manufactured from 
polycarbonate plastic and consisted of four sample wells (each designed 
to receive 25μl of liquid sample), with each sample well connected to a 
channel that leads to an optical chamber.  Beyond each of the four 
optical chambers is a small opening that interfaces with O-rings and a 
pump in the Reader.  This pump was programmed by the Reader 
software to move fluid up and down the channels of the cartridge as 
required.  
C. Swabbing Unit  
The Swabbing Unit was designed and manufactured by the 
University of Huntsville in Alabama (UAH) (see Fig. 5). It consists of a 
hand-held pipette and swabbing device.  Several notches were included 
on the swabbing unit, labeled (from the top): P, W, 1, 2, 3, 4, 5 and 6.  
Notch W was the largest notch and moving the knob up and down in 
this position enabled sample mixing.  Notches 1-6 were of identical size 
and enabled dispensing of uniform 25μl droplets into the sample wells 
of LOCAD-PTS cartridges  (see 
below for a more detailed 
description of these procedures).  
Two swabbing units were 
chosen to launch on STS-116 
(one as a back-up). 
D. Swabbing Kits   
Each swabbing kit consisted 
of a water cartridge, swabbing 
tip and dispensing tip, and was 
designed and manufactured at 
NASA MSFC (see Fig. 6). Each 
swabbing kit consisted of three components: a water cartridge, a swab tip 
and a dispensing tip.  The water cartridge was constructed with two Luer-lok 
valves at either end. The swabbing tip consisted of a polycarbonate Luer-
lok, covered with Dacron material to form a circular tip with a diameter of 
8mm. The capacity of each dispensing tip was 150μl. Each component of 
the swabbing kit was cleaned to remove endotoxin by boiling in 6% 
Figure 3.  LOCAD-PTS 
Figure 4. Cartridge 
Figure 5. Swabbing Unit 
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hydrogen peroxide for at least 20 minutes.  The components and Teflon-980 
material were then dried in a clean, sterile, laminar flow hood. After drying, 
water cartridges were filled with endotoxin-free water (LAL reagent water, 
LRW, product number W110; CRL, Charleston, SC) under a laminar flow 
hood. The swabbing kits were then packaged to include: one full water 
cartridge, one swabbing tip and one dispensing tip. To ascertain cleanliness of 
these swabbing kits, 5 out of every 100 produced were analyzed with LOCAD-
PTS on the ground before launch.  A total of 84 swabbing kits were launched 
on Space Shuttle STS-116. 
E. Media “Contact” slides.   
This investigation used the term ‘media slides’ interchangeably to refer to 
the ‘contact slides’ manufactured by Biotest USA (Denville, NJ). Media slides 
consisted of microbial growth media in the form of a solid gel rectangular pad, 
supported by a plastic (PVC) tray (see Fig. 7 A and B).  This media slide was 
stored in sealed plastic container until use.  When required, the container was 
pealed open (see Fig. 7, C), the media slide removed (see Fig. 7, D) and 
applied to a surface of interest (see Fig. 7, E).  Following surface application, 
the media slide was returned to the container, which was secured with a plastic 
cover seal (see Fig. 7 B).  
 Two types of media slide were used in 
this investigation and referred to as ‘Bacteria’ 
and ‘Fungi’ media slides.  Bacteria media slides 
corresponded to and were identical to the TC 
contact slides from Biotest and consisted of 
tryptic soy agar (product number 931 250 100, 
Biotest USA).  Fungi media slides corresponded 
to and were identical to YM contact slides and 
consisted of Rose Bengal Agar with gentamicin 
sulphate (product number 931 280 100, Biotest 
USA). The surface area of each media slide was 
25cm2 (to meet International Regulations 
USP24 and EP3).  
 
 
III. Procedures 
A. Crew Training   
In general, crewmembers were trained in LOCAD-PTS operations approximately 12-18 months before launch.  
In this experiment, procedures onboard ISS were performed by crewmember Sunita Williams, Peggy Whitson, Dan 
Tani and Greg Chamitoff.  Each received a 1-hour training session in the mock-up ISS U.S. Laboratory facility at 
NASA Johnson Space Center (Houston, TX) several months preceding their mission.  In addition, some 
crewmembers attended a 2-day training session in molecular biology at the Marine Biological Lab (Woods Hole, 
MA) during 2004, where they were familiarized with LOCAD-PTS.  In the JSC training session, Williams was 
trained to perform a complete end-to-end analysis of a surface swab with LOCAD-PTS, with special attention paid 
to operation of the swabbing unit to perform mixing and dispensing operations. 
B. Shipping and pre-launch   
All LOCAD-PTS equipment was packaged by Teledyne Brown Engineering (TBE) at MSFC into a Half Cargo 
Transfer Bag (CTB). The ‘Half’ refers to middeck locker equivalents (MLEs) i.e. a Half CTB will fill half of a 
Space Shuttle middeck locker.  A Half-CTB has a 30 pounds maximum carrying capacity, with the dimensions of 
Figure 7. Media ‘Contact’ Slides 
Figure 6. Swabbing Kit 
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16.75 by 9.75 by 9.25 inches. In order to support and protect equipment against vibrations and shock during ground 
transport and launch, major components (such as the two Readers) were separated by a solid foam material. 
C. Launch and transfer to ISS 
LOCAD-PTS was launched aboard Space Shuttle Discovery (STS-116) on December 9th 2006, which docked 
with the ISS on December 12th 2006.    Following docking, the half-CTB containing LOCAD-PTS was transferred 
to the US Lab of the ISS, and stowed at ambient pressure (15 psi) and temperature (76°F) until use on March 31st 
2007. 
D. Overview of ISS Operations 
Each operating session was defined as either a ‘Phase 1’ session or 
‘Phase 2’ session.  Each Phase 1 session was performed according to the 
surface sampling layout in Fig. 8, with four surface swabs performed 
around two centrally placed media slides (for the culture-based detection of 
fungi and bacteria).  Each of these four swabs was analyzed with LOCAD-
PTS, so that data from LOCAD-PTS culture-based methods were obtained 
for each site.  The duration of a typical phase 1 session was approximately 3 
hours.  Each Phase 2 session consisted of five individual surface swabs of 
separate sites within the ISS; these sessions were slightly shorter than Phase 
1 sessions, running approximately 2-3 hours. The selection of these sites 
were sometimes guided by the LOCAD-PTS operations team, but often left 
to crew discretion.  These Phase 2 sessions constituted an exploratory 
survey of surface endotoxin throughout the ISS. 
A total of five Phase 1 sessions and five Phase 2 sessions were 
performed for LOCAD-PTS LAL analysis of surface endotoxin.  Each 
Phase 1 session was performed by astronaut Suni Williams on March 31st, 
April 30th, May 5th, May 8th and May 15th, 2007. The surface sites chosen for each of these five sessions are shown 
in Fig. 9.  Each of the Phase 2 LAL sessions were performed by astronauts Peggy Whitson and Dan Tani on 
December 20th, 21st and 24th 2007 and February 2nd 2008. Phase 1 Glucan sessions began on June 21st 2008, 
performed by astronaut Greg Chamitoff.  
The LOCAD-PTS operations team 
supported each session from mission control 
at the Payload Operations Integration Center 
(POIC) at MSFC.  Prior to each astronaut’s 
first session, a science conference was 
scheduled so that the crew could discuss 
procedures and scientific objectives with the 
LOCAD-PTS team.  Prior to on-orbit 
operations, all crew procedures were tested 
first by the LOCAD-PTS operations team in 
the microgravity environment of parabolic 
flight (Maule et al., 2004). 
E. Swabbing  
As can be seen from Fig. 8, each LOCAD-PTS swab covered a surface area of 25cm2 (or 2” x 2”), with all four 
swabs surrounding two centrally placed contact slides (for the culture-based detection of bacteria and fungi) during 
Phase 1.  Swabs performed during Phase 2 similarly covered 25cm2 (but contact media slides were not used in Phase 
2).  In this way, both culture-independent and culture-based methods were used together to analyze an approximate 
10” x 10” area (i.e., the grey box in Fig. 8). The crew prepared to swab in this layout by placing four red post-it flags 
on the surface site (see red rectangles in Fig. 8); applying contact slides within those four post-it flags; followed by 
four swabs at the positions indicated.  The swabbing protocol began with direct attachment of the water cartridge of 
the swabbing kit via a push-and-turn action (while the knob of the swabbing unit was at position P).  The water 
cartridge was then attached to the swabbing tip by another push-and-turn action.  At this point the swab unit was in 
Figure 8. Surface sampling layout 
Figure 9. Surface site locations during Phase 1 LAL operations 
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the ‘swabbing configuration’ i.e., a surface sample could be obtained by swabbing a surface with the swabbing tip 
(see Fig. 10).   
F. Mixing  
Following swabbing, the dispensing tip was attached to the swab tip via a push-on O-ring seal.  This is called the 
‘mixing/dispensing configuration’ and at this point, mixing and dispensing took place.  The knob on the swabbing 
unit was manipulated up and down in notch W (see Fig. 5) five times at a rate of once per 2 seconds to mix the swab 
sample with 1.2ml of endotoxin-free water in the water cartridge. Following mixing, the crew performed the 
dispensing procedure (see below).  
G. Dispensing 
Following mixing, the knob of the swabbing unit was left in position 1.  A further droplet was dispensed, and 
then droplets were dispensed into an inserted LOCAD-PTS cartridge by cycling through notches 2-6.  Moving the 
knob down each of the subsequent notches (labeled 1-6) dispensed droplets of approximately 25μl each.  Fig. 11 
shows Suni Williams dispensing a sample onboard the ISS during Phase 1 LAL operations. 
 
 
 
 
 
 
 
 
 
IV. Discussion   
This report describes the operation of a new type of biochemical microbial analysis performed aboard the 
International Space Station (ISS) that builds upon the collective experience and excellent previous studies performed 
in both the United States and Russia, from the early programs of Apollo4,5 and Salyut,13, to space station Mir,10-12, the 
Shuttle-Mir program3 and most recently, the ISS2, 6-9. 
It was the first demonstration of complete biochemical analysis of environmental samples onboard a space 
station from sampling to onboard data.  While the analytical test performed was relatively simple - the Limulus 
Amebocyte Lysate (LAL) assay for detection of endotoxin and β-1, 3-glucan - the demonstration of the technology 
and procedures serves as a foundation for future generations of more specific tests.  The ease with which a variety of 
crewmembers – pilots and scientists – performed procedures was especially important, given that a relatively high 
level of hand-eye coordination and control was required, especially for the dispensing phase of operations.  While 
this procedure might be second nature to a biochemist, it may not so familiar to others, especially in a microgravity 
environment; however, all crewmembers performed procedures equally well throughout each session. 
A potential concern prior to this study was the absence of gloves from crew procedures, which could lead to 
skin-derived biological contamination of the swab tip and false positive readings.  The negative control was 
designed to address this concern (where procedures were performed without a surface swab).  No positive readings 
were obtained during any of the three negative controls performed on orbit – indicating that procedures did not 
introduce contamination to the swab tip (and that the reagents remained clean following extended storage on orbit). 
Figure 10. Swabbing configuration. 
SU = swab unit; W = water cartridge; 
S = swab tip 
Figure 11. Astronaut Suni Williams dispensing a mixed 
surface sample during Phase 1 LAL operations (March, 2007) 
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The waived requirement for gloves is a major advantage given the extra up-mass of clean gloves (and onboard 
storage requirements), down-mass of used gloves, and greater crew time required for gloved operations.  The robust 
design of the cartridges, which enabled handling with bare hands, was a major benefit to operations within the 
distinctly non-sterile ISS cabin environment. 
While there is no general correlation between data endotoxin or β-1, 3-glucan levels and CFU, the two types of 
data can be used together to generate a more complete story of microbial ecology on the ISS.  This approach has 
been implemented im other research areas, from hygiene monitoring on Earth35 to studies of extreme environments 
on Earth, such as Kamchatka36 and the Arctic37.  Onboard culture-independent analysis shall become increasingly 
important following the planned retirement of the Space Shuttle in 2010 (with limited up/down mass for culture-
based systems) and during Constellation missions beyond low Earth orbit.  In response to these events, we shall 
present a set of new microbial monitoring requirements based upon culture-independent parameters measured by 
LOCAD-PTS.   
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Ra6onale: Why monitor bacteria and 
fungi during human space ﬂight? 
1.  Protect Crew Health 
–  Short and Long‐duraCon 
–  Primarily bacteria in drinking water; endotoxin within injectables 
2.  Protect Spacecra[ Hardware 
–  Long‐duraCon only 
–  Primarily fungi on surfaces 
–  Especially in areas inaccessible to cleaning 
3.  Protect Future Science and Planetary Protec6on 
–  During ConstellaCon missions to Moon and Mars 
–  IniCal short‐duraCon stays and later long‐duraCon stays 
–  Precedent: Apollo 7 – 14 (Puleo et al., 1973, 1970) 
–  Airlock and external surfaces (Maule et al., 2005 ‐ 2008) 
Current ISS Requirements  
Bacteria and Fungi on Internal Cabin Surfaces 
Flight Stage  Bacteria (CFU per 100cm2)  Fungi (CFU per 100cm2) 
Pre‐ﬂight  < 500  < 10 
In‐ﬂight  < 10,000  < 100 
Deﬁned in Colony Forming Units (CFU): 
•   Requires culture of samples in growth media 
•   Number of colonies on solid media 
•   Measures bacterial/fungal viable numbers 
•   Detected on ISS surfaces in‐ﬂight using Contact Slides 
Exis6ng method: Surface Sampler Kit (SSK) 
To verify current ISS surface requirements 
•   Part of Crew Health Care System (CHeCS)  
•  “Two SSKs are on board the ISS at all Cmes.  Each SSK contains consumables for a 45‐day 
period, so every 90 days the two kits on board are replaced with two new kits.” [1] 
•   “Provides hardware for taking surface samples from ten loca6ons”. [1] 
•   Bacteria detected up to 4000 CFU per 100cm2; fungi up to 400 CFU per 100cm2“ 
[1] CHeCS Catalog. Version 4.1. April, 
2004. SSK, Sec6on 4.5.   Pages 147 ‐149. 
Media / Contact Slides 
To verify current ISS surface requirements 
•   Agar‐based gel growth media 
•   Applied to contact a surface, incubated for 3 – 5 days 
•   Photographed and assessed on a 1 – 5 scale 
•   Beneﬁt: Targets only viable cells (relevant to crew health) 
•   Beneﬁt: Detects up to 200 CFU per 100cm2 (more stringent than requirements) 
Following typical 5‐day incuba6on 
•  SSK analyzes “up to 4000 CFU per 100cm2 for bacteria”; contact slides up to 
200 CFU per 100cm2.  In‐ﬂight requirement is < 10,000 CFU per 100cm2. 
•  Lengthy analysis (several days). 
•  Does not detect microbes in Viable But Non‐Culturable (VBNC) state: Many 
microorganisms in VBNC state retain toxicity (e.g., Baﬀone, 2003). 
•  Sample return is required for more extensive, molecular analysis 
•  Poten6al growth of harmful microorganisms: Which then require disposal.  
•  Diﬃculty observing colonies: Merging, CondensaCon, Flash photography… 
SSK and Contact Slides: Limita6ons 
Ra3onale for a supplemental culture‐independent system 
Merging colonies a[er several days growth  Condensa6on observed on ISS during 2007 
LOCAD‐PTS Hardware: Reader and Cartridge 
LOCAD‐PTS Hardware: Swab System 
LOCAD‐PTS Biochemistry 
Pro‐phenoloxidase (PPO) Cascade 
Gram‐nega6ve bacteria  Fungi  Gram‐posi6ve bacteria 
LAL  Glucan  LTA CARTRIDGES: 
*LPS and 
Glucan are 
referred to 
collec6vely as 
“Endotoxin” 
* 
* 
LOCAD‐PTS: Schedule and Opera6ons Plan 
Milestone  Start  End  Number 
of 
Sessions 
Crew  Mission 
Launch LOCAD‐PTS and 
LAL Cartridges 
12/9/2006  ‐  ‐  STS‐116  STS‐116 
LAL Tests  3/31/2007  2/2/2008  10 so far  Williams, 
Tani, 
Whitson 
I‐14,  
I‐15, 
I‐16 
Launch Glucan Cartridges  3/11/2008  ‐  ‐  STS‐123  1 J/A 
Glucan Tests  6/21/2008  12/2008  3 so far  Chamitoﬀ, 
Fincke, 
Magnus 
I‐17, 
I‐18 
Launch LTA Cartridges  11/14/2008  ‐  ‐  STS‐126  ULF‐2 
LTA Tests  1/2009  End of 
I‐18 
TBD  Fincke, 
Magnus 
I‐18 
LOCAD‐PTS: Objec6ves 
•   Three Cartridge Types: LAL, Glucan, and LTA 
•   Each Cartridge Type used in two phases: Phase 1 and Phase 2 
•   Phase 1 objec6ves: 
-  Verify funcCon of LOCAD‐PTS Reader, swab system and procedures 
-  Check cleanliness of the swab kits 
-  Target same sites analyzed by CHeCS 
-  Compare LOCAD‐PTS with contact slide data, with four swabs per site 
•   Phase 2 objec6ves: 
-  Survey a large number of diverse sites, with emphasis on crew choice 
-  IdenCfy ‘hot spot’ sites, with one swab per site, no contact slides 
•   Overall objec6ves: 
-  IdenCfy typical endotoxin/glucan/LTA levels throughout ISS (‘space norms’) 
-  Propose new requirements to supplement exisCng CFU requirements.  
LOCAD‐PTS Sampling Procedures 
LAL RESULTS 
March 31, 2007 to February 2, 2008 
CO
N
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CT
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D
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US LABORATORY NODE 1 
•  Highest EU and CFU 
readings found on fabric 
surfaces 
•  EU detected at every site 
where CFU detected 
•  No ‘correla6on’ expected 
between EU and CFU; and 
none observed 
PHASE 1 
DATA 
PHASE 2 DATA 
Category  EU per 100cm2  # Sites 
Absent  < 0.24 – 0.5  11 
Low  0.51 – 1.0  6 
Moderate  1.1 ‐ 10  7 
High  10.1 ‐ 24  1 
Oﬀ‐Scale  > 24  0 
“Space norm”: Absent/Low, with 
Moderate levels common in 
exercise/hygiene areas. 
LOCAD‐PTS Detec6on Limits: 
Minimum = 0.24 EU/100cm2  
Maximum = 24 EU/100cm2  
New surface requirement:  
“ISS internal cabin surfaces shall 
be cleaned in‐ﬂight to a level that 
is < 24 EU/100cm2” (see later).  Hygiene Sta6on  
Wall 
Bathroom  
Mirror 
Phase 2 airlock 
GLUCAN RESULTS 
June 21, 2007 to December 1, 2008 
PRELIMINARY GLUCAN DATA 
Columbus module (COL) Sites: 
ATU  Biolab  
Glovebox 
Category  ng per 100cm2  # Sites 
Absent  < 4.8 ‐ 10  3 
Low  11 ‐ 80  2 
Moderate  81 ‐ 300  3 
High  301 ‐ 480  0 
Oﬀ‐Scale  > 480  0 
“Space norm”:  
Absent/Low, to Moderate 
LOCAD‐PTS Detec6on Limits: 
Minimum = 4.8ng/100cm2  
Maximum = 480ng/100cm2  
New surface requirement:  
“ISS internal cabin surfaces shall 
be cleaned in‐ﬂight to a level that 
is < 480 ng/100cm2” (see later). 
Conclusions 
•  Rapid culture‐independent microbial analysis has been performed 
more than 12 Cmes aboard the ISS since March 2007. 
•  Endotoxin and glucan found predominantly on fabric surfaces and 
sites associated with human ac6vity, where microbial nutrients 
such as sweat, skin, food and water were prevalent.   
•  LOCAD‐PTS acted as a reliable monitor of general biological 
material or “cleanliness”; and “space norms” determined for 
endotoxin and glucan on ISS cabin surfaces. 
•  There can be no general ‘correlaCon’ made between LOCAD‐PTS 
parameters (EU or glucan) and CFU (viable cells), BUT, endotoxin 
was found at every site where CFU were detected on ISS. 
•  On the basis of LOCAD‐PTS data collected so far, supplementary 
requirements are proposed for both general microbial monitoring 
and contaminaCon control, for both ISS and ConstellaCon 
missions…. 
Proposed supplementary requirements  
for monitoring bacteria and fungi on internal cabin surfaces 
Flight Stage  Exis6ng Requirements 
(CFU per 100cm2) 
Supplementary Requirements (Units per 100cm2) 
General* 
(supplements exis6ng) 
Contamina6on control**  
(Constella6on) 
Bacteria  Fungi  Endotoxin 
Units (EU) 
Glucan (ng)  Endotoxin 
Units (EU) 
Glucan (ng) 
Pre‐ﬂight  < 500  < 10  < 0.24  < 4.8  < 0.24  < 4.8 
In‐ﬂight  < 10,000  < 100  < 24  < 480  < 0.24  < 4.8 
* This refers to general microbial monitoring requirements for internal cabin surfaces of 
ISS / ConstellaCon vehicle.  They are intended to supplement exisCng CFU requirements, 
with the aim of protec6ng crew health and spacecra[ hardware. 
** This refers to speciﬁc areas within a manned lunar/Mars lander that are periodically 
exposed to the lunar/MarCan atmosphere and surface (e.g., airlock, spacesuit, and tools), 
with the aim of protec6ng future science and ensuring planetary protec6on. 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